Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011420 |
---|---|
Receipt number | R000013214 |
Scientific Title | Add-on or switch to repaglinide for type 2 diabetes with sitagliptin: Randomized controlled open-labelled trial. |
Date of disclosure of the study information | 2013/08/08 |
Last modified on | 2017/02/18 10:20:51 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/08/08 14:46:18 | ||
2 | Update | 2014/05/28 09:23:14 | TEL Last name of contact person Last name of contact person Address Name of secondary funder(s) Name of secondary funder(s) |
|
3 | Update | 2014/10/20 07:26:05 | Key inclusion criteria Key inclusion criteria |
|
4 | Update | 2017/02/18 10:20:16 | Name of primary person or sponsor Organization |
|
5 | Update | 2017/02/18 10:20:51 | Recruitment status |